Andrea M Pfeifer

USPTO Granted Patents = 36 (Patent Applications = 26)

CIPO Patents = 13 (Patent Applications = 1)

EPO Patents = 26 (Patent Applications = 15)

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 399(Granted Patents)

Location History:

Vevey, CH (1994 - 1996)
Pyrbaum, DE (1996)
1800 Vevey, CH (1997)
Saint-Legier, CH (2002 - 2013)
St-Légier, CH (2007 - 2016)
St.-Légier, CH (2010 - 2017)
St-Legier, CH (2001 - 2018)
St.-Legier, CH (2013 - 2023)

Company Filing History:

Katholieke Universiteit Leuven

patents

5. 2 out of 1,215

The United States of America As Represented by the Department of Health

patents

6. 2 out of 159

Janssen Pharmaceuticals, Inc.

The United States of America As Represented by the Secretary of

10. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12324855 - Method of safe administration of phosphorylated Tau peptide vaccine (2025-06-10),

2. 11684576 - Method of safe administration of phosphorylated tau peptide vaccine (2023-06-27),

3. 10100104 - Methods of diagnosing tau-protein-associated disease (2018-10-16),

4. 10066010 - Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau (2018-09-04),

5. 9701660 - 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system (2017-07-11),

6. 9687447 - Method for preparing liposome-based constructs (2017-06-27),

7. 9657091 - Humanized tau antibody (2017-05-23),

8. 9598485 - Anti-tau antibodies and methods of use (2017-03-21),

9. 9585956 - Polynucleotides encoding anti-amyloid beta monoclonal antibodies (2017-03-07),

10. 9540434 - Phosphospecific antibodies recognising tau (2017-01-10),

11. 9403902 - Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody (2016-08-02),

12. 9304138 - Pharmaceutical composition (2016-04-05),

13. 9221900 - Methods for identifying safe and functional humanized antibodies (2015-12-29),

14. 9175094 - Monoclonal antibody (2015-11-03),

15. 9146244 - Polynucleotides encoding an anti-beta-amyloid monoclonal antibody (2015-09-29),

Title: The Innovative Journey of Andrea M Pfeifer

Introduction: Andrea M Pfeifer, a pioneering inventor hailing from Vevey, Switzerland, has made significant contributions to the field of innovation with her groundbreaking work in various sectors.

Latest Patents: Andrea M Pfeifer's latest patents include cutting-edge technologies in the healthcare industry, focusing on advancements in pharmaceuticals and medical devices that aim to improve patient outcomes and quality of life.

Career Highlights: Throughout her illustrious career, Andrea M Pfeifer has been at the forefront of innovation, leading research and development teams to create novel solutions that address complex challenges. Her dedication to pushing the boundaries of what is possible has earned her recognition as a trailblazer in the world of inventors.

Collaborations: Andrea M Pfeifer has collaborated with top research institutions, universities, and leading companies to bring her innovative ideas to life. By fostering partnerships with experts in various fields, she has been able to leverage diverse perspectives and expertise to drive forward her inventions.

Conclusion: In conclusion, Andrea M Pfeifer's passion for innovation, coupled with her relentless drive to make a positive impact on society, has solidified her reputation as a visionary inventor. Her work continues to inspire the next generation of inventors to think boldly and push the boundaries of what is possible in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.